ORBA Wealth Advisors L.L.C. Purchases 348 Shares of UnitedHealth Group Incorporated $UNH

ORBA Wealth Advisors L.L.C. raised its position in UnitedHealth Group Incorporated (NYSE:UNH) by 10.4% in the 2nd quarter, Holdings Channel.com reports. The firm owned 3,710 shares of the healthcare conglomerate’s stock after buying an additional 348 shares during the period. UnitedHealth Group makes up 1.1% of ORBA Wealth Advisors L.L.C.’s portfolio, making the stock its 28th biggest holding. ORBA Wealth Advisors L.L.C.’s holdings in UnitedHealth Group were worth $1,157,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of the company. HHM Wealth Advisors LLC raised its position in UnitedHealth Group by 0.9% in the first quarter. HHM Wealth Advisors LLC now owns 2,947 shares of the healthcare conglomerate’s stock valued at $1,544,000 after purchasing an additional 26 shares during the last quarter. Brogan Financial Inc. increased its stake in shares of UnitedHealth Group by 3.4% in the first quarter. Brogan Financial Inc. now owns 819 shares of the healthcare conglomerate’s stock valued at $429,000 after buying an additional 27 shares during the period. West Wealth Group LLC increased its stake in shares of UnitedHealth Group by 3.2% in the first quarter. West Wealth Group LLC now owns 882 shares of the healthcare conglomerate’s stock valued at $462,000 after buying an additional 27 shares during the period. Hemington Wealth Management increased its stake in shares of UnitedHealth Group by 2.5% in the first quarter. Hemington Wealth Management now owns 1,154 shares of the healthcare conglomerate’s stock valued at $604,000 after buying an additional 28 shares during the period. Finally, Tlwm grew its stake in UnitedHealth Group by 1.0% during the first quarter. Tlwm now owns 2,736 shares of the healthcare conglomerate’s stock worth $1,433,000 after purchasing an additional 28 shares during the period. 87.86% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

UNH has been the subject of several recent analyst reports. Royal Bank Of Canada raised their target price on UnitedHealth Group from $286.00 to $408.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 29th. Morgan Stanley raised their target price on UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a research note on Friday, September 12th. Truist Financial raised their target price on UnitedHealth Group from $310.00 to $365.00 and gave the stock a “buy” rating in a research note on Tuesday, September 9th. Deutsche Bank Aktiengesellschaft cut UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 price objective for the company. in a research note on Wednesday, October 29th. Finally, Jefferies Financial Group raised their price objective on UnitedHealth Group from $317.00 to $409.00 and gave the company a “buy” rating in a research note on Friday, October 17th. Eighteen research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $397.12.

UnitedHealth Group Stock Down 1.0%

UNH stock opened at $330.56 on Wednesday. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73. The company has a quick ratio of 0.85, a current ratio of 0.82 and a debt-to-equity ratio of 0.71. The stock’s 50 day moving average is $344.70 and its 200-day moving average is $324.06. The firm has a market capitalization of $299.43 billion, a PE ratio of 17.25, a P/E/G ratio of 2.28 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, beating analysts’ consensus estimates of $2.87 by $0.05. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The company had revenue of $113.16 billion for the quarter, compared to analyst estimates of $113.19 billion. During the same quarter last year, the company earned $7.15 earnings per share. The company’s revenue for the quarter was up 12.2% on a year-over-year basis. Sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were issued a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.7%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s dividend payout ratio (DPR) is 46.14%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.